Fortress Biotech, Inc.’s FBIO share price has dipped by 6.18%, which has investors questioning if this is right time to buy.

Vesicor Therapeutics, a San Gabriel-based biotech firm developing p53-based cancer treatments, is set to go public through a ...

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Researchers have discovered a type of molecule that can kill chlamydia bacteria but spare bacteria that are important for health. The discovery opens the door for further research towards developing ...

Biosimilars are gaining traction as competitors aim to capture market share from branded biologics such as Humira and ...

How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function -- defective cell components are marked, disposed ...

99% 12-month and 96% 36-month disease-specific survival in papillary NMIBC without CIS. 10-year cystectomy-free status observed in long-term follow-up of Phase 1 trial. Don’t miss this list of 3 ...

ProBioGen has partnered with Polpharma Biologics to conduct high-performance cell line development services for a biosimilar ...